These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26680924)

  • 1. Pilot Study of Heptaplatin, UFT-E and Leucovorin in Advanced Gastric Carcinoma.
    Oh SC; Yoon SY; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim SY; Yoon HJ; Cho KS; Kim JS
    Cancer Res Treat; 2003 Apr; 35(2):117-22. PubMed ID: 26680924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
    Kim YH; Kim BS; Seo JH; Choi CW; Kim JS; Chun HJ; Hyun JH; Kim JS
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):64-8. PubMed ID: 10442365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
    Wang F; Wang Z; Zhou N; An X; Xu R; He Y; Li Y
    Am J Clin Oncol; 2011 Aug; 34(4):401-5. PubMed ID: 21791984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of haptaplatin/5-FU and leucovorin for advanced stomach cancer.
    Lee WS; Lee GW; Kim HW; Lee OJ; Lee YJ; Ko GH; Lee JS; Jang JS; Ha WS
    Cancer Res Treat; 2005 Aug; 37(4):208-11. PubMed ID: 19956515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.
    Lee KH; Hyun MS; Kim HK; Jin HM; Yang J; Song HS; Do YR; Ryoo HM; Chung JS; Zang DY; Lim HY; Jin JY; Yim CY; Park HS; Kim JS; Sohn CH; Lee SN
    Cancer Res Treat; 2009 Mar; 41(1):12-8. PubMed ID: 19688066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
    Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
    Hortobagyi GN; Heim W; Hutchins L; Rivera E; Mason B; Booser DJ; Kirshner J
    Cancer; 2010 Mar; 116(6):1440-5. PubMed ID: 20091835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase II Trial of UFT-E and Oral Leucovorin in Advanced Colorectal Cancer.
    Lee WS; Lee KS; Kim KH; Ryoo BY; Kim WS; Kang WK; Kang YK; Heo DS; Bang YJ; Kim NK
    Cancer Res Treat; 2001 Jun; 33(3):225-8. PubMed ID: 26680789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with 5-fluorouracil and heptaplatin as first-line treatment in patients with advanced gastric cancer.
    Min YJ; Bang SJ; Shin JW; Kim DH; Park JH; Kim GY; Ko BK; Choi DH; Cho HR
    J Korean Med Sci; 2004 Jun; 19(3):369-73. PubMed ID: 15201502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy of heptaplatin, paclitaxel and 5-fluorouracil in patients with advanced gastric cancer: a pilot study.
    Ahn MJ; Oh HS; Choi JH; Lee YY; Kim IS; Choi IY; Lee OY; Choi HS; Kwon SJ
    Cancer Res Treat; 2004 Jun; 36(3):182-6. PubMed ID: 20396542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusional 5-Fluorouracil, Leucovorin and Docetaxel in Advanced Gastric Cancer.
    Kim YT; Sohn JH; Kim SH; Rha SY; Kim C; Roh JK; Kim BS; Jang WI; Chung HC
    Cancer Res Treat; 2003 Apr; 35(2):123-9. PubMed ID: 26680925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
    González Barón M; Espinosa E; Feliu J; Ordóñez A; Zamora P; de Castro J; García Girón C; García Alfonso P; Garrido P; Belón J; Lomas M
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):109-12. PubMed ID: 9348581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.
    Kim YH; Shin SW; Kim BS; Kim JH; Kim JG; Mok YJ; Kim CS; Rhyu HS; Hyun JH; Kim JS
    Cancer; 1999 Jan; 85(2):295-301. PubMed ID: 10023695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
    Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
    Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.